These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29405076)

  • 1. Tools to investigate and avoid drug-hypersensitivity in drug development.
    Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M
    Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic Cells.
    Galbiati V; Papale A; Kummer E; Corsini E
    Front Pharmacol; 2016; 7():204. PubMed ID: 27462271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of preclinical testing for allergic side effects.
    Bala S; Weaver J; Hastings KL
    Toxicology; 2005 Apr; 209(2):195-200. PubMed ID: 15767036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system.
    Descotes J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):79-83. PubMed ID: 22587937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.
    Pallardy M; Bechara R; Whritenour J; Mitchell-Ryan S; Herzyk D; Lebrec H; Merk H; Gourley I; Komocsar WJ; Piccotti JR; Balazs M; Sharma A; Walker DB; Weinstock D
    Toxicol Sci; 2024 Jun; 200(1):11-30. PubMed ID: 38588579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the THP-1 activation assay to detect pharmaceuticals with potential to cause immune mediated drug reactions.
    Corti D; Galbiati V; Gatti N; Marinovich M; Galli CL; Corsini E
    Toxicol In Vitro; 2015 Oct; 29(7):1339-49. PubMed ID: 26028146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicology: role in the safety assessment of drugs.
    Descotes J
    Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation in drug allergies.
    Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M
    Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.
    Weaver RJ; Betts C; Blomme EAG; Gerets HHJ; Gjervig Jensen K; Hewitt PG; Juhila S; Labbe G; Liguori MJ; Mesens N; Ogese MO; Persson M; Snoeys J; Stevens JL; Walker T; Park BK
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):767-782. PubMed ID: 28604124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro testing for adverse drug reactions.
    Rieder MJ
    Pediatr Clin North Am; 1997 Feb; 44(1):93-111. PubMed ID: 9057786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of drug hypersensitivity.
    Elzagallaai AA; Rieder MJ
    Br J Clin Pharmacol; 2024 Aug; 90(8):1856-1868. PubMed ID: 36519187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review.
    Iammatteo M; Blumenthal KG; Saff R; Long AA; Banerji A
    J Allergy Clin Immunol Pract; 2014; 2(6):768-74. PubMed ID: 25439369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?
    Sullivan A; Gibson A; Park BK; Naisbitt DJ
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):357-68. PubMed ID: 25495340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hypersensitivity: role in drug development.
    Ratajczak HV
    Toxicol Rev; 2004; 23(4):265-80. PubMed ID: 15898831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclinical Tools to Assess Risk of Drug Hypersensitivity Reactions.
    Whritenour J; Casinghino S; Collinge M; Zhu X
    Annu Rev Pharmacol Toxicol; 2016; 56():561-76. PubMed ID: 26514195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug hypersensitivity reactions targeting the skin in dogs and cats.
    Voie KL; Campbell KL; Lavergne SN
    J Vet Intern Med; 2012; 26(4):863-74. PubMed ID: 22519673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Reactions to Biologic Therapy.
    Patel SV; Khan DA
    Immunol Allergy Clin North Am; 2017 May; 37(2):397-412. PubMed ID: 28366484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of transgenic animals to investigate drug hypersensitivity.
    Moser R; Quesniaux V; Ryffel B
    Toxicology; 2001 Feb; 158(1-2):75-83. PubMed ID: 11164996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a human in vitro skin test for predicting drug hypersensitivity reactions.
    Ahmed SS; Whritenour J; Ahmed MM; Bibby L; Darby L; Wang XN; Watson J; Dickinson AM
    Toxicol Appl Pharmacol; 2019 Apr; 369():39-48. PubMed ID: 30768973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.